Education · general-health

Testosterone, Anabolic Steroids and Musculoskeletal Health Info Evidence

Reviewed by Dr Kieran Hirpara, Specialist Orthopaedic Surgeon Last reviewed

What it is

Anabolic steroids are man-made versions of testosterone, the hormone that drives muscle and bone strength in men. Testosterone replacement therapy (TRT) is a prescribed form of testosterone for people whose own levels are low. A newer group of drugs called SARMs (selective androgen receptor modulators) act in a similar way, building muscle without using testosterone itself.

Some people use these drugs to treat a medical condition. Others use them to build muscle for sport or appearance. Both groups should know the drugs affect tendons, the strong cords that join muscle to bone. Research has linked testosterone use with a higher risk of rotator cuff tears [1], biceps tendon injuries [2], and quadriceps tendon injuries within 1 year of filling a prescription [3]. One study found testosterone users had a 2.9-fold increased risk of tendon rupture compared to nonusers [4]. SARM use is also associated with tendon damage [5].

The link seems to work both ways. Too much testosterone appears to strain tendons and joints. Too little causes problems too, because hypogonadism (very low testosterone) seems to have a detrimental effect on the musculoskeletal system [6]. Studies have also connected testosterone levels with osteoarthritis, the wear-and-tear kind of arthritis [7].

If you are on prescribed testosterone and facing surgery, tell your doctor. It changes some risk calculations around operations such as shoulder replacement and rotator cuff repair.

Does it work?

There is no simple answer here, because these drugs do different things in different parts of your body.

Testosterone can build muscle and bone strength. Four randomised controlled trials (studies where people are randomly given a treatment or not) found that testosterone given around the time of surgery improved clinical outcomes, body composition, and bone mineral density in orthopaedic surgeries [8]. Research has also pointed to a possible way to improve fracture healing by targeting the androgen/androgen receptor axis in the periosteum (the thin layer of tissue covering bone) [9].

But the same hormones can strain tendons and joints. Patients who filled a prescription for testosterone replacement therapy were much more likely to experience a quadriceps muscle or tendon injury within 1 year of filling their prescription, and were at increased risk of needing surgical repair of the quadriceps tendon [3]. Patients prescribed at least 3 months of testosterone replacement therapy had a significantly higher incidence of ACL injuries compared to controls within a 2-year follow-up period [10]. Injectable testosterone replacement therapy use within 1 year of primary ACL reconstruction is associated with a 3.3-fold increase in ACL reconstruction revision rates with 2 years of follow-up [11]. A bidirectional Mendelian randomised study (a genetic study that tests cause and effect) supported a causal relationship between bioavailable testosterone levels and osteoarthritis, identifying bioavailable testosterone levels as a risk factor for osteoarthritis [7].

Surgery outcomes are mixed. Patients prescribed supplemental testosterone had a higher risk of all-cause reoperation and reoperation for infection after total shoulder arthroplasty (shoulder replacement) [12]. Preoperative testosterone replacement therapy use was not linked to increased short-term complications after arthroscopic rotator cuff repair (keyhole shoulder tendon surgery) [13]. Patients on testosterone therapy should be counselled about their increased risk for complications following distal biceps tendon repair, and both preoperative risk stratification and optimisation should be employed to minimise perioperative risk [14]. Cessation of testosterone replacement therapy prior to rotator cuff repair should be considered on a patient-specific basis [15]. Anabolic steroids use may contribute to pectoralis major rupture (a tear of the large chest muscle), but continuation during recovery does not seem to have a negative effect on functional recovery [16].

Both too much and too little testosterone seem to have a detrimental effect on the musculoskeletal system (your muscles, tendons, bones and joints) [6].

What are the risks?

The clearest risks sit in your tendons. Research links testosterone use with a higher chance of quadriceps tendon injury [17]. SARM users often take far more than the doses studied, and case reports tie that to tendon damage [18]. Anabolic steroids and very low testosterone can both harm your muscles, tendons, bones and joints [6].

Your joints can be affected too. A genetic study found a causal link between bioavailable testosterone levels and osteoarthritis [7]. The relationship is not a straight line, so keeping testosterone in a healthy range may matter for joint health [19].

If you take testosterone and need surgery, the risks change. Testosterone use is linked with a higher risk of reoperations after shoulder replacement, both for infection and for any reason [20]. It is also a possible risk factor for complications and reoperation after rotator cuff repair, though one study found no link with short-term problems after keyhole rotator cuff surgery [15] [13]. Stopping testosterone before rotator cuff repair is a decision made case by case [15]. Patients on testosterone face a higher risk of complications after distal biceps tendon repair, so doctors assess and prepare you carefully beforehand to lower that risk [14].

Some findings cut the other way. Four randomised controlled trials found testosterone given around the time of surgery improved clinical outcomes, body composition, and bone mineral density in orthopaedic surgeries [8]. Anabolic steroid use may contribute to a pectoralis major rupture, a tear of the large chest muscle, but continuing the drugs during recovery does not seem to harm how well you recover [16].

Some questions remain open. Evidence on whether testosterone supplementation is linked with stroke in young adults is limited and underexplored [21]. And testosterone raises tendon rupture risk in men but not women, possibly because men and women are given different doses [22].

Is it right for you?

These drugs suit different people for different reasons. Prescribed testosterone can help if your own levels are low, and it can build muscle and bone strength. Four randomised controlled trials found testosterone given around the time of surgery improved clinical outcomes, body composition, and bone mineral density in orthopaedic surgeries [8]. But the same hormones can strain tendons and joints, and research links testosterone use with a higher chance of quadriceps tendon injury [17]. A genetic study also found a causal link between bioavailable testosterone levels and osteoarthritis [7]. The relationship is not a straight line, so keeping testosterone in a healthy range may matter for joint health [19].

SARMs are a harder call. They can increase lean body mass at low doses, but case reports suggest users take far more than the doses studied, raising the risk of tendon damage, liver injury and cardiovascular events [18]. SARM use is also associated with liver and heart harm and androgenic side effects throughout the body [5]. There are no good trials showing they are safe, and public health bodies have called for regulation of these grey-market compounds [23].

If you are on testosterone and facing surgery, your doctor should assess your individual risk profile before deciding together [14]. Hormonal status belongs in any assessment of your muscle, tendon and joint risks [24]. This is a shared decision, made with your doctor, based on your own health and goals.

The bottom line

If your testosterone levels are low, prescribed testosterone can help your muscles and bones. But these hormones can strain tendons and joints, and the risks rise with higher doses. If you are facing surgery, tell your doctor about any testosterone or SARM use, because it changes how your risks are assessed. The single most important caveat: both too much and too little testosterone can harm your body, so any decision should be made case by case with your doctor.


References
  1. The Relationship Between Testosterone Therapy and Rotator Cuff Tears, Repairs, and Revision Repairs. *Journal of the American Academy of Orthopaedic Surgeons*. 2023. 10.5435/jaaos-d-22-00554
  2. The use of prescription testosterone is associated with an increased likelihood of experiencing a distal biceps tendon injury and subsequently requiring surgical repair. *Journal of Shoulder and Elbow Surgery*. 2023. 10.1016/j.jse.2023.02.122
  3. Testosterone Therapy Is Associated With Increased Odds of Quadriceps Tendon Injury. *Clinical Orthopaedics & Related Research*. 2023. 10.1097/corr.0000000000002744
  4. Poster 374: Tendon Tears Among Patients Treated with Exogenous Therapeutic Anabolic Steroids: An Eight Year Retrospective Analysis in a Single Institution. *Orthopaedic Journal of Sports Medicine*. 2024. 10.1177/2325967124s00339
  5. Athlete Selective Androgen Receptor Modulators Abuse: A Systematic Review. *The American Journal of Sports Medicine*. 2025. 10.1177/03635465241252435
  6. Testosterone. *JBJS Reviews*. 2024. 10.2106/jbjs.rvw.24.00061
  7. The causal impact of bioavailable testosterone levels on osteoarthritis: a bidirectional Mendelian randomized study. *BMC Musculoskeletal Disorders*. 2025. 10.1186/s12891-025-08626-8
  8. Perioperative Testosterone Supplementation Improves Outcomes of Orthopaedic Surgeries: A Systematic Review of Heterogeneous Studies. *Arthroscopy*. 2024. 10.1016/j.arthro.2024.12.026
  9. Targeted activation of androgen receptor signaling in the periosteum improves bone fracture repair. *Cell Death & Disease*. 2022. 10.1038/s41419-022-04595-1
  10. Prescription Testosterone Is Associated With an Increased Risk of Anterior Cruciate Ligament Injury. *Arthroscopy*. 2024. 10.1016/j.arthro.2024.10.032
  11. Injectable Testosterone Replacement Therapy Within 1 Year Before ACL Reconstruction Is Associated With Increased Revision Rates. *Orthopaedic Journal of Sports Medicine*. 2026. 10.1177/23259671251399845
  12. Poster 149: Supplemental Testosterone Increases Risk of Reoperation after Total Shoulder Arthroplasty. *Orthopaedic Journal of Sports Medicine*. 2024. 10.1177/2325967124s00118
  13. Association of preoperative testosterone replacement therapy with postoperative complications following rotator cuff repair. *Journal of Shoulder and Elbow Surgery*. 2026. 10.1016/j.jse.2025.12.013
  14. Paper 30. Comparative Outcomes of Distal Biceps Tendon Repair in Patients With and Without Testosterone Therapy. *Orthopaedic Journal of Sports Medicine*. 2026. 10.1177/2325967126s00288
  15. Preoperative testosterone replacement therapy: a potential risk-factor for complications and reoperation after rotator cuff repair. *JSES International*. 2026. 10.1016/j.jseint.2025.10.002
  16. Pectoralis major rupture in body builders: a case series including anabolic steroid use. *BMC Musculoskeletal Disorders*. 2023. 10.1186/s12891-023-06382-1
  17. CORR Insights®: Testosterone Therapy Is Associated With Increased Odds of Quadriceps Tendon Injury. *Clinical Orthopaedics & Related Research*. 2023. 10.1097/corr.0000000000002835
  18. Poster 390: Systematic Review of SARMs Abuse in Athletes. *Orthopaedic Journal of Sports Medicine*. 2023. 10.1177/2325967123s00352
  19. Correlation between low testosterone levels and the risk of osteoarthritis: a cross-sectional analysis of NHANES data (2011–2016). *BMC Musculoskeletal Disorders*. 2025. 10.1186/s12891-024-08272-6
  20. Prescription testosterone is associated with increased risk of infection-related and all-cause reoperations after primary total shoulder arthroplasty in male patients. *JSES International*. 2026. 10.1016/j.jseint.2026.101634
  21. Testosterone supplementation and stroke in young adults: a review of the literature. *Frontiers in Neurology*. 2024. 10.3389/fneur.2024.1422931
  22. Testosterone Therapy and Associated Rates of Tendon Tear and Surgical Repair: A Retrospective Analysis. *Orthopaedic Journal of Sports Medicine*. 2026. 10.1177/23259671261430731
  23. Athlete SARMs Abuse: A Systematic Review. *Journal of ISAKOS*. 2023. 10.1016/j.jisako.2023.03.427
  24. Testosterone levels and risk of adhesive capsulitis: a 1:1 propensity matched analysis. *Journal of Shoulder and Elbow Surgery*. 2026. 10.1016/j.jse.2026.01.012
Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • Testosterone replacement therapy is associated with increased odds of surgically treated tendon rupture [1].
  • Anabolic steroids did not induce ultrastructural collagen changes that might predispose to tendon rupture in humans [2].
  • Testosterone users had a 2.9-fold increased risk of tendon rupture compared to nonusers [3].
  • It is premature to imply causation between testosterone replacement therapy and ACL injuries based solely on existing results due to confounding variables [4].
  • Exogenous testosterone is a risk factor for increased postoperative complications following distal biceps tendon repair [5].
  • There is a threshold-dependent relationship between testosterone and shoulder pathology [6].
  • Patients with prior prescription testosterone exposure have an increased rate of distal biceps tendon injury and biceps tendon repair compared with patients without such exposure [7].
  • Surgeons should be more intentional about discussing endocrinologic history with patients and counseling those with testosterone deficiency on the risks for injury or re-injury [8].
  • TRT is associated with increased tendon rupture risk in men but not women, potentially due to sex-specific differences in dosing [9].
  • Patients who filled a prescription for testosterone replacement therapy were much more likely to experience a quadriceps muscle or tendon injury within 1 year of filling their prescription and were at increased risk of undergoing surgical repair of the quadriceps tendon [10].
  • SARM use is associated with tendon damage [11].
  • Cessation of TRT prior to rotator cuff repair should be considered on a patient-specific basis [12].

How It Works

  • Further research is needed to understand the mechanism by how testosterone increases the risk of reoperation after TSA [13].
  • Anabolic steroids use may contribute to pectoralis major injury [14].
  • Continuation of anabolic steroids during recovery does not seem to have a negative effect on functional recovery after pectoralis major injury [14].
  • Testosterone use is associated with a higher risk of both infection-related and all-cause reoperations after total shoulder arthroplasty [15].

What the Evidence Shows

Tendon Rupture Risk and Injury Association

  • Patients who filled a prescription for testosterone replacement therapy were much more likely to experience a quadriceps muscle or tendon injury within 1 year of filling their prescription [10].
  • Patients who filled a prescription for testosterone replacement therapy were at increased risk of undergoing surgical repair of the quadriceps tendon [10].
  • There is increased risk of rotator cuff tears in patients prescribed testosterone [16].
  • There is increased risk of rotator cuff repairs in patients prescribed testosterone [16].
  • There is increased risk of subsequent rotator cuff repairs in patients prescribed testosterone [16].
  • TRT is associated with increased tendon rupture risk in men but not women [9].
  • The association between TRT and increased tendon rupture risk in men but not women is potentially due to sex-specific differences in dosing [9].

Postoperative Complications and Reoperation

  • Testosterone use is associated with a higher risk of infection-related reoperations after total shoulder arthroplasty [15].
  • Testosterone use is associated with a higher risk of all-cause reoperations after total shoulder arthroplasty [15].
  • Supplemental testosterone increases the risk of reoperation after total shoulder arthroplasty [13].
  • Preoperative testosterone replacement therapy is a potential risk factor for complications after rotator cuff repair [12].
  • Preoperative testosterone replacement therapy is a potential risk factor for reoperation after rotator cuff repair [12].

Mechanisms and Ultrastructure

Clinical Considerations and Causation

  • Clinicians should remain vigilant and prescribe TRT judiciously with a thorough assessment of each patient's unique risk profile [4].
  • Surgeons should be more intentional about discussing endocrinologic history with patients [8].
  • Surgeons should counsel patients with testosterone deficiency on the risks for injury or re-injury [8].
  • Further research is needed to understand the mechanism by which testosterone increases the risk of reoperation after total shoulder arthroplasty [13].
  • Hormonal status should be considered in musculoskeletal risk assessment [6].

Practical Considerations

Risk Assessment and Counseling

  • A threshold-dependent relationship exists between testosterone and shoulder pathology, highlighting the need to consider hormonal status in musculoskeletal risk assessment [6].

Operative Considerations

Anabolic Steroids and SARMs

  • SARM use is associated with increased muscle mass, hepatotoxicity, cardiotoxicity, tendon damage, and androgenic side effects throughout the body [11].
  • Anabolic steroids use may contribute to pectoralis major injury in body builders [14].
  • Continuation of anabolic steroids during recovery from pectoralis major injury does not seem to have a negative effect on functional recovery [14].

Key Evidence

  • [L3] Testosterone replacement therapy is associated with increased odds of surgically treated tendon rupture. [1] (10.1177/2325967125s00009)
  • [L4] The authors conclude that anabolic steroids did not induce ultrastructural collagen changes that might predispose to tendon rupture in humans. [2] (10.1016/s0020-1383(98)00183-1)
  • [L3] Testosterone users had a 2.9-fold increased risk of tendon rupture compared to nonusers. [3] (10.1177/2325967124s00339)
  • [L5] It is premature to imply causation between testosterone replacement therapy and ACL injuries based solely on existing results due to confounding variables; clinicians should remain vigilant and prescribe TRT judiciously with a thorough assessment of each patient's unique risk profile. [4] (10.1016/j.arthro.2024.11.086)
  • [L3] These findings suggest that exogenous testosterone is a risk factor for increased postoperative complications following distal biceps tendon repair. [5] (10.1177/2325967126s00288)
  • [L3] These findings suggest a threshold-dependent relationship between testosterone and shoulder pathology and highlight the need to consider hormonal status in musculoskeletal risk assessment. [6] (10.1016/j.jse.2026.01.012)
  • [L3] Patients with prior prescription testosterone exposure have an increased rate of distal biceps tendon injury and biceps tendon repair compared with patients without such exposure. [7] (10.1016/j.jse.2023.02.122)
  • [L5] The author advises surgeons to be more intentional about discussing endocrinologic history with patients and counseling those with testosterone deficiency on the risks for injury or re-injury. [8] (10.1097/corr.0000000000002835)
  • [L3] TRT is associated with increased tendon rupture risk in men but not women, potentially due to sex-specific differences in dosing. [9] (10.1177/23259671261430731)
  • [L3] Patients who filled a prescription for testosterone replacement therapy were much more likely to experience a quadriceps muscle or tendon injury within 1 year of filling their prescription and were at increased risk of undergoing surgical repair of the quadriceps tendon. [10] (10.1097/corr.0000000000002744)
  • [L4] SARM use is associated with increased muscle mass, hepatotoxicity, cardiotoxicity, tendon damage, and androgenic side effects throughout the body. [11] (10.1177/03635465241252435)
  • [L3] Cessation of TRT prior to rotator cuff repair should be considered on a patient-specific basis. [12] (10.1016/j.jseint.2025.10.002)
  • [L3] Further research is needed to understand the mechanism by how testosterone increases the risk of reoperation after TSA. [13] (10.1177/2325967124s00118)
  • [L4] Anabolic steroids use may contribute to the injury, but continuation during recovery does not seem to have a negative effect on functional recovery. [14] (10.1186/s12891-023-06382-1)
  • [L2] Testosterone use is associated with a higher risk of both infection-related and all-cause reoperations after total shoulder arthroplasty. [15] (10.1016/j.jseint.2026.101634)
  • [L3] There is increased risk of RCTs, RCRs, and subsequent RCRs in patients prescribed testosterone. [16] (10.5435/jaaos-d-22-00554)

References

[1] Testosterone Replacement Therapy Increases Odds of Tendon Ruptures Treated Surgically. Orthopaedic Journal of Sports Medicine. 2025. DOI: 10.1177/2325967125s00009

[2] Ultrastructural analysis of ruptured tendon from anabolic steroid users. Injury. 1998. DOI: 10.1016/s0020-1383(98)00183-1

[3] Poster 374: Tendon Tears Among Patients Treated with Exogenous Therapeutic Anabolic Steroids: An Eight Year Retrospective Analysis in a Single Institution. Orthopaedic Journal of Sports Medicine. 2024. DOI: 10.1177/2325967124s00339

[4] Editorial Commentary: Testosterone Replacement Therapy and Anterior Cruciate Ligament Injury Risk: Insights and Cautions for Clinical Application. Arthroscopy. 2024. DOI: 10.1016/j.arthro.2024.11.086

[5] Paper 30. Comparative Outcomes of Distal Biceps Tendon Repair in Patients With and Without Testosterone Therapy. Orthopaedic Journal of Sports Medicine. 2026. DOI: 10.1177/2325967126s00288

[6] Testosterone levels and risk of adhesive capsulitis: a 1:1 propensity matched analysis. Journal of Shoulder and Elbow Surgery. 2026. DOI: 10.1016/j.jse.2026.01.012

[7] The use of prescription testosterone is associated with an increased likelihood of experiencing a distal biceps tendon injury and subsequently requiring surgical repair. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.02.122

[8] CORR Insights®: Testosterone Therapy Is Associated With Increased Odds of Quadriceps Tendon Injury. Clinical Orthopaedics & Related Research. 2023. DOI: 10.1097/corr.0000000000002835

[9] Testosterone Therapy and Associated Rates of Tendon Tear and Surgical Repair: A Retrospective Analysis. Orthopaedic Journal of Sports Medicine. 2026. DOI: 10.1177/23259671261430731

[10] Testosterone Therapy Is Associated With Increased Odds of Quadriceps Tendon Injury. Clinical Orthopaedics & Related Research. 2023. DOI: 10.1097/corr.0000000000002744

[11] Athlete Selective Androgen Receptor Modulators Abuse: A Systematic Review. The American Journal of Sports Medicine. 2025. DOI: 10.1177/03635465241252435

[12] Preoperative testosterone replacement therapy: a potential risk-factor for complications and reoperation after rotator cuff repair. JSES International. 2026. DOI: 10.1016/j.jseint.2025.10.002

[13] Poster 149: Supplemental Testosterone Increases Risk of Reoperation after Total Shoulder Arthroplasty. Orthopaedic Journal of Sports Medicine. 2024. DOI: 10.1177/2325967124s00118

[14] Pectoralis major rupture in body builders: a case series including anabolic steroid use. BMC Musculoskeletal Disorders. 2023. DOI: 10.1186/s12891-023-06382-1

[15] Prescription testosterone is associated with increased risk of infection-related and all-cause reoperations after primary total shoulder arthroplasty in male patients. JSES International. 2026. DOI: 10.1016/j.jseint.2026.101634

[16] The Relationship Between Testosterone Therapy and Rotator Cuff Tears, Repairs, and Revision Repairs. Journal of the American Academy of Orthopaedic Surgeons. 2023. DOI: 10.5435/jaaos-d-22-00554